Collegium to Participate in H.C. Wainwright Global Investment Conference

STOUGHTON, Mass., May 17, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company, today announced that management will present at the H.C. Wainwright Global Investment Conference being held at the Fontainebleau Miami Beach Hotel from May 23-26, 2022.

Details of the event are as follows:
Presentation Date and Time: Tuesday, May 24, 2022, at 3:30 pm ET

About Collegium Pharmaceutical, Inc.
Collegium is a diversified, specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
Head of Investor Relations
[email protected]

You May Also Be Interested In

• Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1
• Republic Technologies Inc. Provides Bi-Weekly Update On Annual Filings
• HAMANASI ADVENTURE & DIVE RESORT, BELIZE RANKED #1 HOTEL IN CENTRAL AMERICA AND #15 IN THE WORLD IN 2026 TRIPADVISOR TRAVELERS’ CHOICE BEST OF THE BEST AWARDS